Semax
Description
Semax is a synthetic peptide fragment derived from adrenocorticotropic hormone (ACTH), developed in Russia and studied extensively in the nootropic and neuroprotective research category. Literature has examined its effects on BDNF, dopamine signaling, and cognitive endpoints in research models. Like Selank, it has been studied through both injectable and intranasal protocols. Each vial is manufactured to pharmaceutical-grade purity and shipped lyophilized for stability. For research and laboratory use only.
